This paper on the amyloid hypothesis I wrote in September/October 2022, with a minor part added after the lecanemab trial data (Van dyck et al.) that came out in November 2022 (see also this other paper on lecanemab: https://zenodo.org/record/7500723). Working now with collaborators to improve this for a good journal and hope to see it published in 2023. Copyright © 2022-2023 Professor Kasper Planeta Kepp, DTU, Denmark. License CC BY-NC-ND. Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work, tables or text phrases are permitted
In 1906, Alois Alzheimer described the neuropathologyof the disease that was to bear his name.1 Subs...
One of the earliest cerebral changes in patients with Alzheimer’s disease is the accumulation of amy...
The current conceptualization of Alzheimer disease (AD) is driven by the amyloid hypothesis, in whic...
International audienceThe amyloid cascade hypothesis (ACH) has dominated contemporary biomedical res...
The first description of Alzheimer's disease (AD) was made in 1907 by Alois Alzheimer (Allgemeine Ze...
The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the bra...
Copyright © 2012 Laura Morelli et al. This is an open access article distributed under the Creative ...
The pathogenesis of Alzheimer's disease is complex. The amyloid hypothesis has directed research eff...
Fil: Morelli, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordina...
Alzheimer's disease (AD), the most common cause of dementia in the elderly is a common neurodegenera...
© 2014 Morris et al.; licensee BioMed Central Ltd. The amyloid hypothesis has driven drug developmen...
Although the prevalence of dementia continues to increase worldwide, incidence in the western world ...
Treball Final de Grau en Química. Codi: QU0943. Curs acadèmic: 2019/2020Alzheimer's disease (AD) is ...
PURPOSE OF REVIEW: This article discusses the recent advances in the diagnosis and treatment of A...
Abstract Alzheimer’s disease (AD) is a common neurodegenerative disease characterized clinically by ...
In 1906, Alois Alzheimer described the neuropathologyof the disease that was to bear his name.1 Subs...
One of the earliest cerebral changes in patients with Alzheimer’s disease is the accumulation of amy...
The current conceptualization of Alzheimer disease (AD) is driven by the amyloid hypothesis, in whic...
International audienceThe amyloid cascade hypothesis (ACH) has dominated contemporary biomedical res...
The first description of Alzheimer's disease (AD) was made in 1907 by Alois Alzheimer (Allgemeine Ze...
The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the bra...
Copyright © 2012 Laura Morelli et al. This is an open access article distributed under the Creative ...
The pathogenesis of Alzheimer's disease is complex. The amyloid hypothesis has directed research eff...
Fil: Morelli, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordina...
Alzheimer's disease (AD), the most common cause of dementia in the elderly is a common neurodegenera...
© 2014 Morris et al.; licensee BioMed Central Ltd. The amyloid hypothesis has driven drug developmen...
Although the prevalence of dementia continues to increase worldwide, incidence in the western world ...
Treball Final de Grau en Química. Codi: QU0943. Curs acadèmic: 2019/2020Alzheimer's disease (AD) is ...
PURPOSE OF REVIEW: This article discusses the recent advances in the diagnosis and treatment of A...
Abstract Alzheimer’s disease (AD) is a common neurodegenerative disease characterized clinically by ...
In 1906, Alois Alzheimer described the neuropathologyof the disease that was to bear his name.1 Subs...
One of the earliest cerebral changes in patients with Alzheimer’s disease is the accumulation of amy...
The current conceptualization of Alzheimer disease (AD) is driven by the amyloid hypothesis, in whic...